Donor-specific antibodies against HLA-C, HLA-DP and HLA-DQ and their implications in kidney transplantation
{{output}}
HLA-C, HLA-DP and HLA-DQ are thought to be benign due to low expression and few initial negative studies. Historically, most allocation programs used HLA-A, HLA-B and HLA-DR antigens for matching. With the advent and use of single-bead antigen assays, more was... ...
